{"id":"W2179646396","doi":"10.1007/s40261-015-0336-0","title":"Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe","year":2015,"lang":"en","type":"review","venue":"Clinical Drug Investigation","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Guanfacine; Atomoxetine; Medicine; Stimulant; Methylphenidate; Dopamine; Context (archaeology); Attention deficit hyperactivity disorder; Monoaminergic; Pharmacology; Norepinephrine; Pharmacotherapy; Neuroscience; Psychiatry; Psychology; Clonidine; Receptor; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004885284,0.0002930893,0.0005574392,0.0004867878,0.0001689923,0.0005468936,0.0003101462,0.000843704,0.00440215],"category_scores_gemma":[0.0003417279,0.00008876024,0.0004756181,0.000410624,0.0002653282,0.0008013048,0.0004726316,0.001314149,0.001085506],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004006096,"about_ca_system_score_gemma":0.0005917941,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006670817,"about_ca_topic_score_gemma":0.001556285,"domain_scores_codex":[0.9998379,0.00003062716,0.00003311484,0.00003669935,0.0000378337,0.00002391224],"domain_scores_gemma":[0.9998159,0.00004991073,0.00006003241,0.000005984831,0.00003065922,0.00003760395],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005020412,0.0001820789,0.001291003,0.002588062,0.0001101273,0.001335707,0.000070213,0.0002520767,0.004923194,0.005296107,0.01985007,0.9635994],"study_design_scores_gemma":[0.0005095117,0.00112234,0.01121975,0.00343624,0.0002139876,0.0106569,0.0001090783,0.0003127077,0.001423832,0.002815099,0.9681369,0.0000435819],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01177924,0.9553876,0.001319011,0.008238114,0.00085298,0.00003799246,0.0002796791,0.0001025358,0.02200271],"genre_scores_gemma":[0.06859875,0.8978758,0.005661222,0.01306555,0.001913644,0.00008255329,0.0008834965,0.00005138566,0.01186757],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00440215,"threshold_uncertainty_score":0.0147267,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3967785501146209,"score_gpt":0.5193796967377047,"score_spread":0.1226011466230837,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}